Quantcast

Latest Medicago Stories

2011-08-17 06:00:00

FIVE POINTS, Calif., Aug. 17, 2011 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) today announced it is shipping its first commercial scale alfalfa seed order destined for the new country of North Sudan. The sale is for a selection of S&W's proprietary non-dormant, salt tolerant, seed alfalfa varieties that have been carefully chosen with a view to growing conditions in North Sudan. The Company is keenly interested in North and South Sudan because of their role in the Company's...

2011-06-22 06:00:00

- 2011 "Prix Sant©" presented by the Armand-Frappier Foundation - - 2011 Genesis Entrepreneurship Award presented by BIOQuebec - QUEBEC CITY, June 22, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced today that it was named this month both the recipient of the 2011 "Prix Sant©" awarded by the...

2011-06-21 06:30:00

FIVE POINTS, Calif., June 21, 2011 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW), announced today the retention of Lytham Partners, LLC to conduct a national investor relations program. Mark S. Grewal, president and CEO of S&W Seed Company, commented, "S&W is now firmly positioned in three markets: production and marketing of high salt- and heat-tolerant alfalfa seed, the natural sweetener market via our new stevia planting program, and seed cleaning and processing for...

2011-06-21 06:00:00

APPROVED FOR PUBLIC RELEASE, DISTRIBUTION UNLIMITED RALEIGH, NC and QUEBEC CITY, June 21, 2011 /PRNewswire/ - Medicago USA Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the third milestone payment of US$5.6 million from the Defense Advanced Research Projects Agency...

2011-05-26 06:30:00

QUEBEC CITY, May 26, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is...

2011-04-13 10:20:00

QUEBEC CITY, April 13 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced today that it was named "Best Early-Stage Vaccine Biotechnology Company" at the recently held World Vaccine Congress in Washington, D.C. Medicago was also a finalist in the "Best Prophylactic Vaccine" category along with Sanofi, GSK, Novartis, Baxter and...

2011-04-06 06:00:00

QUEBEC CITY, April 6 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company. Under the terms of the research collaboration, Medicago will apply...

2011-03-15 06:00:00

APPROVED FOR PUBLIC RELEASE, DISTRIBUTION UNLIMITED RALEIGH AND QUEBEC CITY, March 15 /PRNewswire-FirstCall/ - Medicago USA Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the second milestone payment of US$3.8 million from the Defense Advanced Research Projects Agency...

2011-03-14 15:06:00

QUEBEC CITY, March 14 /PRNewswire/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Mr. Pierre Labbe, Chief Financial Officer will present a corporate update at the 23(rd) Annual Roth OC Growth Stock Conference on Tuesday, March 15, 2011 at 8:00 a.m. Pacific Time at The Ritz Carlton Laguna Niguel in Dana Point,...

2011-02-15 06:00:00

QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Ms. Nathalie Landry, Vice President of Product Development, is invited to present at the 7(th) WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. The conference is being held at the World...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related